Weight loss pill Wegovy now available in German pharmacies
Since September 1, 2026, the new medication Wegovy has been available in German pharmacies. The drug is a tablet that contains the active ingredient semaglutide. The medication was specifically approved for the treatment of obesity and is intended to support patients in weight reduction.
Although there is significant public interest in new weight loss supplements, pharmacists have so far reported rather reserved demand. In the first few days following the market launch, there were only a few inquiries from customers in many pharmacies. Experts are now observing how interest will develop in the coming weeks.
The medication is available by prescription only, which means that patients must consult a doctor before taking it. Doctors decide on an individual basis whether the use of the drug is medically appropriate and safe. Treatment with semaglutide should also always be accompanied by professional advice on nutrition and lifestyle.
The introduction of Wegovy in tablet form represents a new option for patients who previously relied on other weight loss methods. Health authorities and medical professionals will closely monitor the effects and tolerability of the medication in the near future to gain further insights into its long-term efficacy.